JNJ Is Down 10% in 44 Days. What History Says Now

JNJ Is Down 10% in 44 Days. What History Says

The last time Johnson & Johnson (JNJ) was at a severity level this extreme was during a period of heightened market volatility that tested even the most stable healthcare giants. As of May 4, 2026, our data shows the stock has officially crossed a critical threshold, moving from the green zone into the yellow zone. This transition signals a shift in risk profile for one of the market's most consistent performers.

Breaking Down the Move to the Yellow Zone

As of May 4, 2026, Johnson & Johnson (JNJ) is trading at $224.20. This price represents a -9.8% drawdown from its all-time high of $248.56. While a 10% drop might seem standard for many equities, it is significant for a stock with JNJ’s historical profile. Our proprietary Drawdown Severity Score™ currently sits at 2.3, which classifies the asset as being in a state of "Moderately Elevated" risk.

The current sell-off has lasted 44 days. To put this in perspective, the average drawdown duration for this stock across its entire history is 42 days. By crossing the 44-day mark, the current decline has officially lasted longer than the historical average. This duration, combined with the depth of the price drop, is what triggered the shift from the green zone to the yellow zone in our monitoring system.

Historical Context and Severity Score™ Metrics

We have tracked a total of 329 historical drawdown events for Johnson & Johnson (JNJ). Across this massive dataset, the average maximum drawdown for the stock is only -3.6%. The current -9.8% decline is nearly triple the historical average, explaining why the Drawdown Severity Score™ has escalated so quickly.

When analyzing the most severe historical outcomes, we find that JNJ has dropped 30% or more only 5 times in its history. These deep corrections are rare but grueling: the average duration of these comparable drops is 807 days. While the current 44-day decline is far from a 30% crash, the move into the yellow zone suggests that the stock is entering a phase where volatility typically begins to cluster.

How JNJ Ranks Across the Market

In the context of the broader market, a Drawdown Severity Score™ of 2.3 is a measured signal. It indicates that while the stock is no longer in a "business as usual" state, it has not yet reached the red zone levels of distress often seen in high-growth tech stocks or cyclical commodities. However, for a healthcare staple like Johnson & Johnson (JNJ), any move into the yellow zone warrants attention because of the stock's role as a defensive anchor in many portfolios.

Our data shows that when JNJ enters this specific severity range, it often stays there until a clear catalyst emerges to either break the trend or accelerate the decline. The fact that the current drawdown has already exceeded the average duration of 42 days suggests that the market is currently repricing the stock's risk premium. We are monitoring whether the price can stabilize near the current $224.20 level or if the Drawdown Severity Score™ will continue to climb toward the 3.0 mark.

Interpreting the Current Trajectory

The move from the green zone to the yellow zone is a objective data event. It tells us that the current price action is no longer a standard "noise" pullback. By reaching a -9.8% drawdown, JNJ is testing a level of support that has historically acted as a pivot point for the stock. In past instances where the severity score reached this level, the recovery time has varied significantly depending on broader sector health.

We use the Drawdown Severity Score™ to strip away the emotional narrative of "cheap" or "expensive." Instead, we focus on the statistical reality of the price action. As of May 4, 2026, the data confirms that JNJ is experiencing a drawdown that is deeper and longer than its historical norm. Investors who track these zones use the yellow zone as a prompt to review their risk exposure and prepare for potential further volatility or a stabilization period.

We will continue to track the Drawdown Severity Score™ for Johnson & Johnson (JNJ) daily. Any move back toward the green zone would require a sustained move toward the $240 level, while a further slide toward a 15% drawdown would likely push the severity score into the high 3s or low 4s.